JPRN-UMIN000007245已完成未知
Optimal reversal dose of Sugammadex in a short post-operative period in adult patients - Optimal dose of Sugammadex after rocuronium administration
Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University0 个研究点目标入组 40 人开始时间: 2012年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •the patients were ASA physical status 3-4. the diabetic patients. the patients who heve neurodegenerating disease.
研究者
相似试验
进行中（未招募）
1 期
Sugammadex dose-finding study for reversal of deep rocuronium-induced neuromuscular blockEUCTR2019-000709-55-BEniversitair Ziekenhuis Brussel60
已完成
不适用
Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium.Patients scheduled for elective surgery requiring general anesthesiaJPRN-UMIN000025218Department of Anesthesiology Nihon University School of Medicine40
进行中（未招募）
1 期
Minimal optimal dose of Sugammadex during ambulatory surgery in dentistrywomen and men> 18 years of age Elective Surgery BMI <30, patients who gave consent to free and informed participation in writing to benefit from tooth extractionEUCTR2017-005074-19-BEErasme Hospital40
尚未招募
Unknown
To Evaluate the Efficacy of Sugammadex in Reversing the effect of a Muscle Relaxant in Patients Undergoing Major Upper Abdominal Surgery: An Observational StudyCTRI/2023/07/055172Dr. Ram Manohar Lohia Institute of Medical Sciences
尚未招募
4 期
A clinical trial to compare the effectiveness of two drugs (sugammadex vs neostigmine-glycopyrolate)in patient undergoing cardiac surgeries.CTRI/2024/08/072509Vignesh D